Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1979-03-05
1980-05-13
Ore, Dale R.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424304, 424305, 424320, A61K 3122, A61K 31275, A61K 31215, A61K 3116
Patent
active
042029023
ABSTRACT:
Lipogenesis in mammals is inhibited by certain cyclopropanecarboxylic acids, esters and amides.
REFERENCES:
patent: 3989722 (1976-11-01), Cognacq
patent: 4080474 (1978-03-01), Hindley et al.
Senior et al., Chem. Abs., 1966, vol. 65, p. 19168.
Senior et al., Chem. Abs., 1967, vol. 67, p. 107062g.
Duncombe et al., Chem. Abs., 1968, vol. 69, p. 94244g.
Carr John B.
Durham Harry G.
Ore Dale R.
Shell Oil Company
LandOfFree
Lipogenesis control by cyclopropane-carboxylic acids, esters and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipogenesis control by cyclopropane-carboxylic acids, esters and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipogenesis control by cyclopropane-carboxylic acids, esters and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-929955